|
|
|
Insider
Information: |
Jaen Juan C. |
Relationship: |
President |
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
371,475 |
|
Indirect Shares
|
1,188,233 |
|
|
Direct
Value |
$6,705,728 |
|
|
Indirect Value
|
$17,906,671 |
|
|
Total
Shares |
1,559,708 |
|
|
Total
Value |
$24,612,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-71.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-15 |
4 |
OE |
$4.30 |
$8,364 |
D/D |
1,945 |
53,700 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-19 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
53,700 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-20 |
4 |
OE |
$4.30 |
$24,084 |
D/D |
5,601 |
50,601 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-21 |
4 |
OE |
$4.30 |
$4,730 |
D/D |
1,100 |
46,100 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-22 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-25 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-26 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
47,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-27 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
49,901 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-28 |
4 |
OE |
$4.30 |
$21,926 |
D/D |
5,099 |
50,000 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-27 |
4 |
B |
$7.44 |
$75,217 |
I/I |
10,106 |
2,774,346 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-28 |
4 |
B |
$7.89 |
$38,637 |
I/I |
4,894 |
2,779,240 |
2.66 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2019-06-03 |
4 |
B |
$8.25 |
$82,485 |
I/I |
10,000 |
2,764,240 |
2.66 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2012-12-17 |
4 |
AS |
$10.95 |
$82,375 |
D/D |
(7,500) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2012-12-18 |
4 |
AS |
$11.05 |
$83,375 |
D/D |
(7,500) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-02 |
4 |
AS |
$11.25 |
$65,568 |
D/D |
(5,821) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-03 |
4 |
AS |
$11.35 |
$1,135 |
D/D |
(100) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-04 |
4 |
AS |
$11.35 |
$1,090 |
D/D |
(96) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-12 |
4 |
AS |
$11.35 |
$37,512 |
D/D |
(3,305) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-22 |
4 |
AS |
$11.35 |
$1,135 |
D/D |
(100) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-24 |
4 |
AS |
$11.35 |
$13,622 |
D/D |
(1,200) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-25 |
4 |
AS |
$11.35 |
$1,090 |
D/D |
(96) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-28 |
4 |
AS |
$11.35 |
$30,851 |
D/D |
(2,710) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-29 |
4 |
AS |
$11.45 |
$56,013 |
D/D |
(4,892) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-01-31 |
4 |
AS |
$11.45 |
$37,752 |
D/D |
(3,280) |
53,000 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-01 |
4 |
AS |
$11.60 |
$78,106 |
D/D |
(6,725) |
53,000 |
0 |
- |
|
92 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|